|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Downregulation of several fibulin genes in prostate cancer显示文摘 | AgnesWlazlinski RainerEngers Michèle J.Hoffmann ChristianeHader VolkerJung MirkoMüller Wolfgang A.Schulz | 2007 | Prostate2007，，16： | 2 |
| 2 | Follow up evaluation of a phase Ⅱ prostate cancer vaccine trial显示文摘 | Tjoa BA Simmens SJ Elgamal A | 1999 | Prostate1999，40，2： | 2 |
| 3 | Oncologic Outcomes of Asian Men with Clinically Localized Prostate Cancer after Extraperitoneal Laparoscopic Radical Prostatectomy: A Single-Institution Experience显示文摘 | Huai-Ching Tai Ming-Kuen Lai Chao-Yuan Huang Shuo-Meng Wang Kuo-How Huang Shiu-Dong Chung Shih-Chieh Jeff Chueh Hong-Jeng Yu Hendrik van Poppel | 2010 | Prostate Cancer2010，，： | 2 |
| 4 | Effect of a phytotherapeutic agent, Eviprostat?, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis显示文摘 | MikioSugimoto MichikoOka HiroyukiTsunemori MotokiYamashita YoshiyukiKakehi | 2011 | Prostate2011，，4： | 2 |
| 5 | Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides显示文摘 | Tjoa BA Erickson SJ Brwes VA | 1997 | Prostate1997，32，1： | 2 |
| 6 | Immuno-histochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy显示文摘 | Ranganathan S Salazar H Benetatos CA | 1997 | Prostate1997，30，4： | 1 |
| 7 | Differential expression of interleukin-15,a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate显示文摘 | Handisurya A Steiner GE Stix U | 2001 | Prostate2001，49，： | 1 |
| 8 | Angiotensin Ⅱ type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer显示文摘 | Kosaka T Miyajima A Takayama E | 2007 | Prostate2007，67，1： | 1 |
| 9 | Prediction of extraprostatic cancer by prostate specific antigen density,endorectal MRI,and biopsy Gieason score in clinically localized prostate cancer 显示文摘 | Horiguchi A Nakashima J Horiguchi Y | 2003 | Prostate2003，56，1： | 1 |
| 10 | Soy isoflavone genistein in prevention and treatment of prostate cancer 显示文摘 | Perabo FG Von EC Ellinger J | 2008 | Prostate Cancer Prostatic Dis2008，11，： | 1 |
| 11 | Screening decreases prostate cancer mortality:11-year follow-up of the 1988 Quebec prospective randomized controlled trial显示文摘 | Labile F Candas B Cusan L | 2004 | Prostate2004，59，3： | 1 |
| 12 | Magnetic resonance imaging of the axial skrleton enables objective measurement of tumor response on prostate cancer bone metastases显示文摘 | Tombal B Rezaxadch A Therassc P | 2005 | Prostate2005，65，2： | 1 |
| 13 | Voltage-gated K~ channel activity in human prostate cancer cell lines of markedly different metastatic potential: distinguishing characteristics of PC3 and LNCaP cells 显示文摘 | Laniado ME Fraser SP Djamgoz MBA | 2001 | Prostate2001，46，4： | 1 |
| 14 | Defining regulatory elements in the human KAI1/CD82 metastasis suppressor gene显示文摘 | GAO AC LOU W DONG JT | 2003 | Prostate2003，57，4： | 1 |
| 15 | Effects of the somatostatin analog Lanreotide on the circulating level of chromogranin - A, prostate - specific antigen, and insulin like growth factor - 1 in advanced prostate cancer patients 显示文摘 | Berruti A Dogliotti L Mosca A | 2001 | Prostate2001，47，3： | 1 |
| 16 | 1alpha, 25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway 显示文摘 | Murthy S Weigel NL | 2004 | Prostate2004，59，3： | 1 |
| 17 | Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance显示文摘 | Ng CP Zisman A Bonavida B | 2002 | Prostate2002，53，4： | 1 |
| 18 | Expression of NF-кB in prostate cancer lymph node metastases显示文摘 | Ismail Ha Lessard L Mes-Masson AM | 2004 | Prostate2004，58，3： | 1 |
| 19 | Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the ini tiation and progression of prostate cancer显示文摘 | Uzgare AR Kaplan PJ Greenberg NM | 2003 | Prostate2003，55，2： | 1 |
| 20 | Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer mode显示文摘 | Shanmugam R Jayaprakasan V Gokmen-Polar Y | 2006 | Prostate2006，66，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员